Commonwealth Equity Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.5M | Buy |
54,972
+829
| +2% | +$387K | 0.03% | 494 |
|
|
2025
Q4 | $24.5M | Sell |
54,143
-4,142
| -7% | -$1.79M | 0.03% | 494 |
|
|
2025
Q3 | $22.8M | Sell |
58,285
-1,113
| -2% | -$465K | 0.03% | 515 |
|
|
2025
Q2 | $26.4M | Sell |
59,398
-6,346
| -10% | -$2.92M | 0.03% | 482 |
|
|
2025
Q1 | $31.9M | Buy |
65,744
+1,624
| +3% | +$757K | 0.05% | 394 |
|
|
2024
Q4 | $25.8M | Buy |
64,120
+693
| +1% | +$321K | 0.04% | 447 |
|
|
2024
Q3 | $29.5M | Sell |
63,427
-22,148
| -26% | -$10.6M | 0.04% | 402 |
|
|
2024
Q2 | $40.1M | Buy |
85,575
+6,368
| +8% | +$2.76M | 0.06% | 292 |
|
|
2024
Q1 | $33.1M | Buy |
79,207
+4,662
| +6% | +$1.97M | 0.06% | 335 |
|
|
2023
Q4 | $30.3M | Buy |
74,545
+5,598
| +8% | +$2.07M | 0.06% | 324 |
|
|
2023
Q3 | $24M | Sell |
68,947
-588
| -0.8% | -$206K | 0.05% | 348 |
|
|
2023
Q2 | $24.5M | Buy |
69,535
+2,225
| +3% | +$750K | 0.05% | 355 |
|
|
2023
Q1 | $21.2K | Buy |
67,310
+1,015
| +2% | +$304K | 0.04% | 383 |
|
|
2022
Q4 | $19.1M | Buy |
66,295
+2,992
| +5% | +$912K | 0.05% | 383 |
|
|
2022
Q3 | $18.3M | Sell |
63,303
-7,743
| -11% | -$2.23M | 0.05% | 363 |
|
|
2022
Q2 | $20M | Buy |
71,046
+206
| +0.3% | +$55.1K | 0.05% | 346 |
|
|
2022
Q1 | $18.5M | Buy |
70,840
+5,437
| +8% | +$1.29M | 0.04% | 395 |
|
|
2021
Q4 | $14.4M | Sell |
65,403
-9,388
| -13% | -$1.83M | 0.03% | 472 |
|
|
2021
Q3 | $13.6M | Buy |
74,791
+9,820
| +15% | +$1.92M | 0.03% | 463 |
|
|
2021
Q2 | $13.1M | Buy |
64,971
+12,489
| +24% | +$2.61M | 0.03% | 466 |
|
|
2021
Q1 | $11.3M | Sell |
52,482
-6,957
| -12% | -$1.53M | 0.03% | 478 |
|
|
2020
Q4 | $14M | Buy |
59,439
+13,889
| +30% | +$3.19M | 0.04% | 387 |
|
|
2020
Q3 | $12.4M | Buy |
45,550
+5,930
| +15% | +$1.64M | 0.04% | 374 |
|
|
2020
Q2 | $11.5M | Buy |
39,620
+19,673
| +99% | +$5.33M | 0.04% | 368 |
|
|
2020
Q1 | $4.75M | Buy |
19,947
+2,393
| +14% | +$549K | 0.02% | 571 |
|
|
2019
Q4 | $3.84M | Buy |
17,554
+2,339
| +15% | +$473K | 0.01% | 707 |
|
|
2019
Q3 | $2.58M | Sell |
15,215
-735
| -5% | -$130K | 0.01% | 844 |
|
|
2019
Q2 | $2.92M | Sell |
15,950
-369
| -2% | -$64.5K | 0.01% | 775 |
|
|
2019
Q1 | $3M | Buy |
16,319
+721
| +5% | +$133K | 0.01% | 740 |
|
|
2018
Q4 | $2.58M | Buy |
15,598
+150
| +1% | +$26K | 0.01% | 724 |
|
|
2018
Q3 | $2.98M | Buy |
15,448
+4,990
| +48% | +$889K | 0.01% | 744 |
|
|
2018
Q2 | $1.78M | Buy |
10,458
+591
| +6% | +$91.6K | 0.01% | 959 |
|
|
2018
Q1 | $1.61M | Buy |
9,867
+603
| +7% | +$98.5K | 0.01% | 996 |
|
|
2017
Q4 | $1.39M | Sell |
9,264
-268
| -3% | -$39.7K | 0.01% | 1044 |
|
|
2017
Q3 | $1.45M | Sell |
9,532
-1,014
| -10% | -$153K | 0.01% | 984 |
|
|
2017
Q2 | $1.36M | Buy |
10,546
+6
| +0.1% | +$722 | 0.01% | 991 |
|
|
2017
Q1 | $1.15M | Buy |
10,540
+1,481
| +16% | +$130K | 0.01% | 1048 |
|
|
2016
Q4 | $667K | Sell |
9,059
-749
| -8% | -$60.9K | ﹤0.01% | 1250 |
|
|
2016
Q3 | $855K | Buy |
9,808
+433
| +5% | +$40.9K | 0.01% | 1089 |
|
|
2016
Q2 | $806K | Buy |
9,375
+2,376
| +34% | +$205K | 0.01% | 1090 |
|
|
2016
Q1 | $556K | Buy |
6,999
+1,342
| +24% | +$121K | 0.01% | 1260 |
|
|
2015
Q4 | $712K | Buy |
5,657
+399
| +8% | +$48.2K | 0.01% | 1102 |
|
|
2015
Q3 | $548K | Buy |
5,258
+305
| +6% | +$39.2K | 0.01% | 1197 |
|
|
2015
Q2 | $612K | Sell |
4,953
-1,052
| -18% | -$133K | 0.01% | 1219 |
|
|
2015
Q1 | $708K | Sell |
6,005
-340
| -5% | -$40.7K | 0.01% | 1137 |
|
|
2014
Q4 | $754K | Buy |
6,345
+1,208
| +24% | +$136K | 0.01% | 1044 |
|
|
2014
Q3 | $577K | Sell |
5,137
-5,330
| -51% | -$507K | 0.01% | 1161 |
|
|
2014
Q2 | $991K | Buy |
10,467
+2,522
| +32% | +$177K | 0.01% | 872 |
|
|
2014
Q1 | $562K | Buy |
7,945
+1,841
| +30% | +$146K | 0.01% | 1104 |
|
|
2013
Q4 | $454K | Sell |
6,104
-1,672
| -22% | -$116K | 0.01% | 1188 |
|
|
2013
Q3 | $590K | Buy |
7,776
+523
| +7% | +$41.6K | 0.01% | 1007 |
|
|
2013
Q2 | $581K | Buy |
+7,253
| New | +$534K | 0.01% | 952 |
|
Other funds holding VRTX
VCM
VPM
Commonwealth Equity Services's VRTX Position: Q1 2026 in Review
Commonwealth Equity Services increased its Vertex Pharmaceuticals (VRTX) stake by 1.5% in Q1 2026, buying an estimated $387K and bringing the position to 54,972 shares worth $24.5M. The position accounts for 0.03% of the portfolio, ranked #494.
Commonwealth Equity Services first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.1M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Commonwealth Equity Services held 54,972 shares of Vertex Pharmaceuticals worth $24.5M as of Q1 2026.
- Commonwealth Equity Services bought 829 Vertex Pharmaceuticals shares in Q1 2026, an estimated $387K.
- Vertex Pharmaceuticals made up 0.03% of Commonwealth Equity Services's portfolio in Q1 2026, its #494 holding.
- Commonwealth Equity Services first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Commonwealth Equity Services's Vertex Pharmaceuticals position peaked at $40.1M in Q2 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.